Qube Research & Technologies (QRT)
BMY icon

Qube Research & Technologies (QRT)’s Bristol-Myers Squibb BMY Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.1M Buy
248,200
+9,700
+4% +$565K 0.02% 1040
2025
Q4 		$12.9M Sell
238,500
-330,600
-58% -$15.9M 0.01% 1176
2025
Q3 		$25.7M Sell
569,100
-288,900
-34% -$13.5M 0.03% 775
2025
Q2 		$39.7M Buy
858,000
+698,200
+437% +$34.3M 0.04% 554
2025
Q1 		$9.75M Sell
159,800
-523,400
-77% -$30.5M 0.01% 1155
2024
Q4 		$38.6M Sell
683,200
-96,100
-12% -$5.37M 0.05% 470
2024
Q3 		$40.3M Buy
779,300
+468,200
+150% +$22M 0.06% 409
2024
Q2 		$12.9M Buy
311,100
+191,500
+160% +$8.57M 0.02% 806
2024
Q1 		$6.49M Sell
119,600
-307,700
-72% -$15.7M 0.01% 1070
2023
Q4 		$21.9M Buy
427,300
+403,000
+1,658% +$21.2M 0.04% 482
2023
Q3 		$1.41M Buy
+24,300
New +$1.49M ﹤0.01% 1569
2019
Q2 		– Sell
-100,000
Closed -$4.77M – 415
2019
Q1 		$4.77M Buy
+100,000
New +$4.98M 0.63% 38

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BMY Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Bristol-Myers Squibb (BMY) stake by 32% in Q1 2026, buying an estimated $45M and bringing the position to 3,203,665 shares worth $194M. The position accounts for 0.22% of the portfolio, ranked #96.

Qube Research & Technologies (QRT) first reported a position in BMY in Q1 2018 and has held it in 22 quarters since. The position peaked at $451M in Q2 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Qube Research & Technologies (QRT) held 3,203,665 shares of Bristol-Myers Squibb worth $194M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 772,565 Bristol-Myers Squibb shares in Q1 2026, an estimated $45M.
  • Bristol-Myers Squibb made up 0.22% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #96 holding.
  • Qube Research & Technologies (QRT) first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 22 quarters since.
  • Qube Research & Technologies (QRT)'s Bristol-Myers Squibb position peaked at $451M in Q2 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.